key: cord-0912645-pyl35u58 authors: Eddens, Taylor; Parks, Olivia B.; Williams, John V. title: Neonatal Immune Responses to Respiratory Viruses date: 2022-04-14 journal: Front Immunol DOI: 10.3389/fimmu.2022.863149 sha: 2f8aa51102d6f6238e76ff9ea28ef4d8f5898fe6 doc_id: 912645 cord_uid: pyl35u58 Respiratory tract infections are a leading cause of morbidity and mortality in newborns, infants, and young children. These early life infections present a formidable immunologic challenge with a number of possibly conflicting goals: simultaneously eliminate the acute pathogen, preserve the primary gas-exchange function of the lung parenchyma in a developing lung, and limit long-term sequelae of both the infection and the inflammatory response. The latter has been most well studied in the context of childhood asthma, where multiple epidemiologic studies have linked early life viral infection with subsequent bronchospasm. This review will focus on the clinical relevance of respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and rhinovirus (RV) and examine the protective and pathogenic host responses within the neonate. cases (11, 12) . While progression to bronchiolitis requiring hospitalization is relatively rare (1-2% of all RSV cases), RSV accounts for nearly 70% of all hospitalizations for bronchiolitis in the United States (13, 14) . Global estimates of RSV disease are staggering, with 3.2 million hospital admissions and 59,600 inhospital deaths in 2015; 45% of hospitalizations (~1.4 million) and deaths (~27,300) were in infants under the age of 6 months (2) . Premature infants are at especially high risk, with one metaanalysis indicating 3-fold higher risk of hospitalization in premature compared to term infants (15) . HMPV is a negative-sense single-stranded RNA virus first isolated from children with lower respiratory tract infection by Dutch investigators in 2001 (16). HMPV is also a member of the Pneumoviridae family (16-18). HMPV largely occurs in the winter and early spring months in the United States, typically 1-2 months after the peak of RSV season (19) (20) (21) (22) . Most children are infected with HMPV within the first years of life, although reinfection can occur frequently with either heterologous or homologous strains of HMPV (22, 23) . HMPV infection most commonly presents in children with fever, rhinorrhea, and cough, while wheezing on presentation has been reported in approximately 50% of pediatric cases (22, 24, 25) . One prospective multicenter surveillance study demonstrated that HMPV causes 7% of sick clinic and emergency department visits for children <5 years of age (26) . In 2018, HMPV infections globally in children under the age of 5 years contributed to approximately 500,000 hospital admissions and 11,300 deaths (3) . Infants had a disproportionately high risk of hospitalization and death-a trend that was magnified in lowincome or low-middle-income countries (3) . Infants with history of prematurity also have increased susceptibility to hospitalization and severe HMPV disease (26) (27) (28) (29) . Human rhinoviruses are positive-sense single-stranded RNA virus in the family Picornaviridae and genus Enterovirus (30) (31) (32) . Rhinovirus (RV) infection most commonly occurs in the fall with a smaller peak in the spring (33, 34) . The mean age for first symptomatic RV infection is approximately 6 months, with reinfection via heterologous strains occurring frequently (35, 36) . RV infection has a range of presentations: asymptomatic (occurring frequently in young children), upper respiratory tract infection (known colloquially as the 'common cold'), and lower respiratory tract infection (37) (38) (39) (40) (41) (42) . However, RV is a frequent cause of lower respiratory tract infection in infants and toddlers, causing common presentations of bronchiolitis, pneumonia, and wheezing episodes (43) (44) (45) (46) (47) (48) (49) (50) . Hospitalization among children with RV was disproportionately seen in infants <6 months, with RV infection accounting for~5 out of every 1,000 hospitalizations in this age range (51) . Like RSV and HMPV, RV infection can cause severe disease in premature infants; in fact, nosocomial outbreaks of RV have been described in neonatal intensive care units (52) (53) (54) . Collectively, RSV, HMPV, and RV represent three leading causes of respiratory morbidity and mortality in young children, highlighting the need to understand host-pathogen interactions in the lung that put these patients at higher risk of poor outcomes. The unique immunologic functions of the neonatal lung in homeostasis shape the responses to these three pathogens. Structurally, the lungs in utero undergo three major developmental stages characterized by histologic appearance: pseudoglandular, canalicular, and terminal saccular stages (55) . When the lungs spring open with the newborn's first cry, the primary functions of ventilation and oxygenation begin as residual amniotic fluid is absorbed. However, for the next 4 weeks in mice and the next 1-2 years in humans, the last stage of development, alveolarization, occurs. This process is marked by increased branching and budding of alveoli, exponentially increasing the surface area of cells capable of performing gasexchange (55) . As infectious threats to the newborn lung can be present from that first breath, it is unsurprising that development of the immune system within the lung occurs early in embryonic development (56) . Immune cells, particularly embryonic macrophages and dendritic cells, can be found in the lung as early as embryonic day(E) 9.5 in mice and E35 in humans (57, 58) . NK cells are present early in fetal development in the murine liver and spleen at E14.5 and 15.5, respectively (59) . Shortly after, gd T cells develop in the embryonic thymus and are important sources of prenatal IL-17 (60, 61) . Proteins like mucins (e.g. Muc5b) and surfactants (e.g. SP-A) are released from the prenatal lung into the amniotic fluid and both substances have immunomodulatory properties (62) (63) (64) (65) (66) . Shortly after birth, the composition of the innate immune system in the lung changes. Single-cell RNA sequencing of post-natal day 1 mice demonstrate the presence of 5 unique subsets of macrophages/monocytes and 3 subsets of dendritic cells (DCs), as well as mast cells, basophils, and neutrophils (67) . Interestingly, the monocytes present in the murine lung prenatally differentiate into long-lived alveolar macrophages within the first week of life in a GM-CSF-dependent fashion (68) . Following LPS stimulation, murine neonatal macrophages have increased production of IL-10 (an anti-inflammatory cytokine); IL-1, IL-6 and TNF production were significantly decreased following LPS stimulation, potentially due to decreased TLR2 and TLR4 expression ( Figure 1 ) (69). Between postnatal day 3-21 in mice, macrophages in the neonatal lung show increased polarization towards an M2-like macrophage phenotype, which is temporally associated with alveolarization (70) . In contrast, phagocytic function and bactericidal capabilities of neonatal macrophages isolated from human cord blood are comparable to that of adult cells (71, 72) . Human cord blood derived macrophages stimulated with LPS do not decrease their oxygen consumption, indicating an impaired ability to modulate metabolism and effectively activate macrophages, while adult macrophages downregulate oxidative phosphorylation, thus shifting to Warburg metabolism (73) . Human cord blood derived macrophages and monocytes are also less responsive to IFN-g compared to adult cells (74) . In humans, circulating monocytes in the newborn exhibit decreased MHC class II expression, which leads to impaired antigen presenting capacity in tissues (75) . Cord blood monocytes have an intrinsic impairment in extravasation under homeostatic conditions when compared to adult monocytes, although activation of endothelial cells by inflammation can improve neonatal monocyte migration (76) . In the newborn mouse, absolute number and function of DCs are decreased compared to the adult lung (77, 78) . Neonatal lung DCs in mice promote tolerance by upregulating PD-L1 expression shortly after birth in a microbiota-dependent fashion (79) . Human cord blood derived DCs have decreased expression of MHC class II and co-stimulatory molecules such as CD25, CD83, and CD86 and exhibit blunted responses to LPS (80, 81). Following LPS stimulation, human neonatal conventional DCs (cDCs) have impaired transcription of IL12-p35, a subunit of the Th1-potentiating cytokine IL-12p70, although this expression was restored by exogenous IFN-g administration (82, 83) . Similarly, stimulation of human cord blood DCs with TLR7 and TLR9 agonists demonstrated defective type I interferon responses (84, 85) . Interestingly, murine neonatal DCs may have a constrained response to TLR stimulation in part due to IL-10 production by CD5 + B cells, demonstrating the complex interplay of neonatal innate and adaptive immunity (86, 87) . In a human cohort followed prospectively, IFN-a production by DCs increased to adult levels by 1 year of age, IL-10 production declined to adult levels by 2 years, while IL12-p70 secretion remained decreased at 2 years (88) . While similarities in decreased co-stimulatory molecule expression and blunted inflammatory responses in DCs have been characterized, other differences between murine and human DCs responses to specific stimulations have been reviewed elsewhere (89) . More recently, fate-mapping and sequencing based techniques in mice have demonstrated that cDC2s derived early in life have differing responses to pathogens compared to the adult cDC2s due to an altered cytokine milieu in the lung, rather than inherent pre-programmed differences (90) . Although absolute numbers of neutrophils are comparable to that of older children and adults, neonatal neutrophils exhibit poor chemotaxis, endothelial adhesion, and phagocytic function (91) (92) (93) . Human neonatal neutrophils neither produce neutrophil extracellular traps (NETs) nor respond to Fasmediated apoptosis as effectively as adult neutrophils (94) (95) (96) (97) . FIGURE 1 | Baseline differences in the neonatal innate immune system. Several areas of the innate response are blunted in neonates, including macrophage response to TLR signals, neutrophil/monocyte extravasation, and poor function of antigen-presenting cells (monocytes/dendritic cells). Anti-inflammatory signals are also produced by the innate system, with IL-10 production via macrophages. Dendritic cells express PD-L1, a co-inhibitory receptor, shortly after birth and produce less pro-inflammatory IL-12. NK cells show reduced effector function and increased expression of inhibitory receptors (e.g. NKG2A). Eosinophils accumulate in the lung within the first two weeks of life in mice. Created with biorender.com. One study also identified a unique group of myeloid suppressor cells with a neutrophilic/granulocytic phenotype (Gr-MDSC) in human cord blood; this cell population was found to suppress NK cell activation and T cell polarization to effector subsets (98) . NK cells in the human lung exhibit a selective tolerogenic phenotype where they retain their ability to generate strong antibody-dependent cell-mediated cytotoxicity (ADCC) responses similarly to adult NK cells, but are unable to mount a response against cells displaying non-self peptide or lacking MHC class I receptor (99) . Analysis of human cord blood revealed that NK cells have increased expression of inhibitory receptors (e.g. NKG2A/CD94) and decreased expression of activation receptors (e.g. leukocyte immunoglobulin-like receptor (LIR)-1), leading to impaired recognition of MHC-I negative cells (100) (101) (102) . Human cord blood derived NK cells also had decreased toll-like receptor 3 (TLR3) expression and failed to mount a response to polyinosinic-polycytidylic acid (poly(I:C)), a synthetic viral double-stranded RNA viral pathogen-associated molecular pattern, but paradoxically had increased IFN-g release with TLR8 stimulation (103, 104) . NK cells isolated from cord blood also had a 3-fold lower capacity for cytolytic activity and decreased degranulation and cytokine production (e.g. IL-15, IL-2, granzyme B, and IFN-g) compared to adult NK cells (100, (105) (106) (107) . Maturation of neonatal murine NK cells into adult-like NK cells was constrained by TGF-b signaling (108) . While comparing murine-derived data from lung tissue with peripherally acquired human cells presents a challenge, a pattern of anti-inflammatory and tolerogenic responses from neonatal innate immune cells emerges. Stimuli that would normally initiate a robust inflammatory response in adult models, such as LPS or other pathogen-associated molecular patterns, have blunted effects on neonatal dendritic cells and macrophages (69, 73, (82) (83) (84) (85) (86) . Further, innate immune cells in the neonate contribute to the local anti-inflammatory milieu by production of IL-10 with suppression of 'typical' inflammatory cytokines (e.g. IL-12), upregulation of co-inhibitory receptor (e.g. PD-L1) expression, and reduced co-stimulatory receptor expression (69, (79) (80) (81) (82) (83) 88) .. Collectively, these alterations not only stifle an inflammatory innate response in the neonatal lung, but also effect downstream adaptive immunity as well. Although once thought to be in a relative state of immunosuppression due to poor adaptive immunity, recent studies clearly demonstrate the presence of a more nuanced adaptive immune response in the neonate (109) (110) (111) (112) . Single cell RNA sequencing demonstrated T cell and B cell numbers increase in the murine neonatal lung on the first day of life (67, 113) . This early arrival in the lungs is not necessarily in response to a stimulus, but reflective of the fact that neonatal naïve T cells extravasate into end-organ sites to a higher degree than adult naïve T cells (114) (115) (116) . Following trafficking to the lung, the adaptive immune system of the neonate has strikingly different properties than adult counterparts (117, 118) . This concept has been described as a 'layered immunity,' as neonatal B and T cells have functional differences that phenotypically distinguish these cells (119) (120) (121) (122) (123) .. While CD8 + T cells are present in the murine newborn lung at a relatively low abundance, exposure to pathogens can lead to rapid induction of CD8 + T cells (67, 113, 124, 125) . Neonatal CD8 + T cells demonstrate greater proliferative capabilities with rapid terminal differentiation at the expense of memory formation ( Figure 2 ) (123, (126) (127) (128) . From a functional perspective, neonatal CD8 + T cells demonstrate decreased cytotoxicity but increased innate-like characteristics, such as antimicrobial peptide production and reactive oxygen species formation (118, 129) . Furthermore, antigen-naïve murine CD8 + T cells in the neonate can secrete IFN-g in response to cytokine stimulation alone, suggesting less reliance on TCR signaling (118, 123) . IL-12 in particular appears to be a key cytokine in changing the epigenetic landscape of human neonatal CD8 + T cells, shifting functionality towards a more 'adult' phenotype (130, 131) . Similar to the findings of neonatal CD8 + T cells, neonatal CD4 + T cells have greater proliferative capabilities (117, 132) , a more restrictive T cell receptor (TCR) repertoire with bias towards self-reactive TCRs (133) (134) (135) , and are more likely to become terminally differentiated rather than form a memory population (136) . However, neonatal CD4 + T cells have significant heterogeneity in differentiation states (e.g. subsets) and effector function. Compared to adult cells, murine CD4 + T cells found after birth skew towards Th2 and away from Th1 cells ( Figure 2 ) (137-139). Neonatal CD4 + T cells produce an abundance of IL-4 and IL-13 after activation, in part due to hypomethylation of a key murine Th2 cytokine regulatory region (CNS-1) and an open IL-13 locus resistant to transcriptional repression in human cells (140) (141) (142) . This epigenetic pattern in T cells in mice changes rapidly post-birth, reaching adult-like epigenetic patterns within 6 days of life and thus contributing to this notion of a "critical window" of Th2 bias (143) . In murine Th1 cells, lack of IL-12 in the milieu leads to upregulation of IL-13Ra1, allowing for IL-4 signaling through the IL-4 receptor which results in induction of apoptosis, furthering the imbalance of Th2/Th1 cells (144) (145) (146) . In addition to favoring the Th2 subset, naïve T cells from the neonate preferentially differentiate into regulatory T cells (Tregs) (117, 132) . Using a fate-mapping Foxp3 mouse, Tregs generated early in life in the lung demonstrated suppressive activity that was maintained into adulthood (147) . Similarly, in humans, Tregs directed against maternal alloantigens could be detected in children 7-17 years old, suggesting a long-lived functionality of neonatal Tregs (148) . To a lesser extent than Th2/Treg skewing, one murine fate-mapping model showed increased neonatal T cell differentiation towards Th17 cells (149) . Human cord blood derived T cells cultured in Th17-polarizing conditions produced higher levels of IL-22, an anti-inflammatory cytokine designed at maintaining epithelial barriers, when compared to adult T cells (150) . T follicular helper (Tfh) cells, a Bcl6-dependent CD4 + T cell subset that specializes in facilitating germinal center reactions and B cell development, also show altered function in neonates (151) . In studies of neonatal immunization, induction and migration of Tfh cells were impaired compared to adult mice (152, 153) . Further, impaired Tfh cell function in neonates led to reduced germinal center quantity, less differentiation of B cells towards plasma cells, and reduced antigen-specific IgG production when compared to adult mice (152) . While neonatal Tfh cells demonstrate some degree of intrinsic dysfunction, the extrinsic milieu in the neonate also plays a factor; for instance, IL-4 seems to promote Tfh cell development and localization to germinal centers, while simultaneously constraining IL-17 production by Tfh cells and skewing the humoral response towards IgE production (152, 153) . Using microarray, a more recent study demonstrated that neonatal Tfh cells can initiate the transcriptional program associated with Tfh development, but preferentially differentiate into short-lived pre-Tfh cells more so than adult counterparts (154) . Further, these neonatal Tfh cells also expressed a signature more classically associated with Th2 cells, such as increased expression of IL-13 and transcription factors associated with Th2 development (154) . While the diminished function of Tfh cells in neonates contributes to the changes in the humoral response, there are also key differences between neonatal and adult B cells. The murine and human neonatal B cell compartment is largely composed of a first layer of B-1 B cells arising from the embryonic yolk sac and fetal liver, compared to mature B-2 cells in the adult (120) . Murine B-1 cells, unlike B-2 cells, do not require IL-7 or B cell activating factor (BAFF) for development FIGURE 2 | Baseline differences in the neonatal adaptive immune system. The neonatal CD4 + T cell compartment is skewed towards Th2 (due to hypomethylation of critical Th2 regulatory regions) and Treg development. There is less differentiation towards Th1 due to reduced IL-12 in the milieu, coupled with increased Th1 apoptosis due to IL-4 signaling. Tfh cells, while stimulated by IL-4 to differentiate, have arrested development, with generation of short-lived pre-Tfh cells. IL-4 signaling on Tfh cells also limits IL-17 production and skews the humoral response towards IgE production. Both neonatal Tfh and B cells have poor migration to germinal centers, which structurally demonstrate poor organization. B cells also have increased production of IL-10 and spontaneous secretion of IgM. CD8 + T cells show radically different properties in neonates compared to adults, with increased proliferation, generation of reactive oxygen species (ROS) and antimicrobial peptides (AMPs), and reduced cytotoxicity and memory formation. Created with biorender.com. and are more responsive to TSLP (155, 156) . Neonatal B cells in mice also have low levels of activation induced cytidine deaminase (AID) leading to lower affinity antibody responses (157) . Human cord blood derived B-1 cells have a more restricted immunoglobulin repertoire, spontaneously secrete IgM, and exhibit limited somatic hypermutation (158) . Passive humoral immunity, though, is provided via transplacental transfer of high-titer maternal antibodies, which occurs in humans during the third trimester of pregnancy (159) (160) (161) . Taken together, these studies not only indicate that the neonatal lung has a coordinated first layer of adaptive immunity at baseline, but are also identifying the mechanistic differences between neonatal and adult adaptive immunity. The evolutionary reasons for these altered responses remains an active question. Considering the altered CD4 + T cell response as a prototypical example, the Th2-predominance may be critical for lung development, as evidenced by the temporal association of polarization of M2-like macrophages and recruitment of eosinophils with alveolarization and primary septation, respectively (70, 162) . Additionally, there is a theological argument to be made for limiting a potentially inflammatory and cytotoxic Th1 response in area of active development. While sustaining a milieu favoring Th2 vs. Th1 cells in the neonatal lung under physiologic conditions presumably confers some evolutionary advantage to the host, understanding this baseline difference-along with the others discussed in these last two sections-informs how the neonatal immune system responds in the face of a viral infection. Several neonatal animal models exist to study the host-pathogen interactions of respiratory viruses, with the most extensive body of literature surrounding neonatal RSV infection. RSV infection of newborn mice resulted in prolonged viral replication when compared to adult mice, although neonates are capable of controlling and clearing infection (163, 164) . Neonatal epithelial cells release IL-33 and TSLP in greater magnitude following RSV infection compared to adult mice ( Figure 3 ) (165, 166) . Early mediators of antiviral response such as recruitment of plasmacytoid DCs (pDCs) and production of IFN-a and IFN-b were deficient in neonatal mice infected with RSV (167). cDC1s were adequately recruited to the lung, but failed to respond to type I IFNs and upregulate co-stimulatory molecules (e.g. CD80/ CD86) required for proficient CD8 + T cell response following RSV infection in mice (168) . cDCs from human cord blood infected with RSV similarly had poor co-stimulatory molecule expression (168) . Antigen-specific CD8 + T cells were induced in neonatal mice following RSV infection but were less likely to produce IFN-g (169) . This lack of IFN-g production leads to a delayed and blunted classically activated macrophage response in neonatal mice (163) . TLR4 or TLR9 agonist treatment increased co-stimulatory molecule expression on murine cDCs and restored CD8 + T cell responses to adult levels (170) . Interestingly, the CD8 + T cell repertoire following RSV infection is significantly different in neonatal mice with variations in epitope-specific Vb repertoire usage and lower functional avidity, a finding that resolves within 2 weeks of life, highlighting a critical window for altered CD8 + T cell responses (164) . Neonatal RSV infection in mice was associated with recruitment of CD4 + T cells with a Th2 bias (171) . Compared to adult mice, the CD4 + T cell compartment of neonatal mice showed increased proliferative capacity, expression of IL-4Ra, and differentiation into Th2 cells following RSV infection (172) . Using a lamb model, neonatal RSV infection further increased Th2 cytokine production in the setting of an elevated baseline Th2 milieu (173) . This skewing towards type 2 inflammation (e.g. increased ILC2s and Th2s) was due to rapid and increased production of IL-33 in neonatal mice (165, 174) . Consistent with a Th1/Th2 imbalance, neonatal mice had fewer Th1 CD4 + cells in the bronchoalveolar lavage fluid when compared to adult mice (171) . RSV infection of 7-day-old mice resulted in long-standing pathophysiologic changes such as reduced lung function, chronic inflammation, and airway remodeling; synergistic changes were noted in mice sensitized to OVA after prior neonatal RSV infection (175) . Re-infection 4-6 weeks after initial neonatal infection led to an exaggerated Th2 response and increased airway hyperresponsiveness when compared to weanling-aged or adult-aged mice infected twice with RSV (172, 176) . Mechanistically, neonatal mice with repeated exposure to RSV demonstrated a break in tolerance to an antigen (OVA) present in maternal breastmilk, increasing susceptibility to allergic airway disease (177) . It should also be noted that RSV strain virulence could also play a role in mediating pathology, as a chimeric RSV A2 strain carrying the F protein from a clinical isolate induced a more robust Th2 response and subsequent lung pathology (178) . Murine Th2 responses following neonatal RSV infection contribute to pathology. CD4 + T cell-specific deletion of IL-4Ra led to reduced Th2 responses and reduced airway hyperresponsiveness following secondary exposure (172) . Similarly, administration of an IL-4Ra antisense oligonucleotide during the initial neonatal infection mitigated Th2-mediated pathology with subsequent RSV exposure (179) . Interestingly, administration of recombinant IFN-a during primary infection led to reduced pathology with re-infection, in part by limiting increased IL-4Ra on Th2 cells (167) . Amelioration of altered airway responses after secondary infection could also be achieved with administration of an IL-13Ra2 fusion protein, blockade of IgE, blockade of IL-33 signaling, or inhibition of STAT6 during the primary infection (165, 176, 180, 181) . The lack of a strong Th1 response in neonates also may contribute to pathology. RSV-infected human cord blood DCs produce increased TGF-b, an anti-inflammatory cytokine that in this context limits IL-12p70 production (and subsequent Th1 differentiation), compared to RSV-infected DCs derived from adults (182) . Recombinant IFN-g therapy diminished the number of GATA3 + CD4 + T cells (Th2) and increased antigen-specific CD8 + T cell recruitment to BAL fluid (171). Recombinant IFN-g treatment in mice activates classically activated and alveolar macrophages and leads to improved RSV clearance (163, 183) . Likewise, neonatal infection with a recombinant RSV strain expressing IFN-g led to improved viral clearance with primary infection and reduced pathology upon secondary infection (184) . Collectively, these studies suggest that diminishing an exuberant Th2 response or enhancement of a deficient Th1 response can limit RSV-induced pathology. Type 17 immunity has been implicated in protection and pathology in neonatal RSV infection. To recapitulate the clinical phenomenon of infants with CX3CR1 gene variants having worse outcomes with RSV infection, Das et al. evaluated neonatal RSV infection in mice lacking this chemokine receptor (185, 186) . Cx3cr1 knockout mice also had worsened pathology dependent on increased IL-17 from gd T cells (185) . Administration of IL-22, a cytokine produced by Th17 cells, Th22 cells, and others to neonatal mice infected with RSV led to faster reduction in RSV burden by limiting RSV-mediated subversion of autophagy (187) . RSV infection of a subgroup neonatal B cells named B regulatory cells (nBregs) derived from human cord blood occurs through interaction with the chemokine receptor CX3CR1; infection of nBregs led to secretion of IL-10, further blunting the Th1 response (188) . From a humoral perspective, neonatal mice produced RSVspecific IgE after infection, consistent with a Th2 bias (181) . However, neonatal mice had a less robust RSV-specific neutralizing IgG response compared to adult mice (189) . Interestingly, depletion of CD4 and CD8 T + cells, NK cells, or IFN-g blockade led to enhanced RSV-specific antibody production in the neonates (189) . The poor antibody response in neonates was the result of poor germinal center activity and deficient differentiation of CD4 + T cells to the follicular helper (Tfh) subset (190) . Mice lacking Tfh cells had increased pathology with re-exposure to RSV, while blockade of IL-2 led to increased Tfh number, reduced RSV-driven pathology, and increased RSV-specific IgG production (190) . Interestingly, administration of recombinant IFN-a during neonatal RSV infection led to increased B cell trafficking to the lung, increased B-cell activating factor (BAFF) and a proliferationinducing ligand (APRIL) expression, and increased RSV-specific IgA (191) . Another member of the Pneumoviridae family, pneumonia virus of mice (PVM), has been utilized as a murine model of early life lower respiratory tract infection (192, 193) . Unlike RSV or HMPV, however, PVM is a natural murine pathogen; this allows for the investigation of infection dynamics and the resultant immune response in context of a natural host-pathogen dyad (192) . Although kinetics of PVM infection were similar between neonatal and adult mice, neonatal mice had markedly reduced pro-inflammatory mediator production and leukocyte recruitment (194) . In a model of severe bronchiolitis using IRF7-deficienct mice, neonatal infection with PVM led to release of IL-33 and HMGB1 (high-mobility group box 1), another nuclear alarmin, both of which contributed to ILC2 proliferation, type 2 inflammation, and airway remodeling (195) . Similar to neonatal models of RSV, early life PVM coupled with exposure to an allergen led to Th2-driven phenotype mirroring asthma (196, 197) . The relationship between neonatal infection and type 2 inflammation has also been well characterized in a neonatal RV model. RV infection in mice at DOL7 led to detectable viral RNA for 7 days, accompanied by inflammatory cell infiltration and upregulation of IL-13 in the acute phase (198) . However, pathology persisted 4 weeks after initial exposure, as mice with neonatal RV infection had exaggerated airway hyperresponsiveness compared to age-matched uninfected controls and RV-infected adult mice (198) . Interestingly, these late-phase pathologic effects were mitigated by anti-IL-13 treatment in the immediate postinfectious period (198) . Neonatal RV infection resulted in induction of IL-33, IL-25, and TSLP-all of which are epithelial derived cytokines implicated in asthma pathogenesis-and in this model contributed to type 2 innate lymphoid cells (ILC2) expansion (199) (200) (201) . Neonatal infection with RV followed by a challenge with a heterologous strain of RV lead to increased expansion of this pathologic ILC2 population, perhaps serving as a murine model of the clinical response in children with frequent RV re-exposure (202) . Additionally, sensitization to an unrelated antigen (e.g. OVA) followed by antigen challenge led to worsening airway hyperresponsiveness in mice with a history of neonatal RV infection (198) . There were strain differences observed as well, as neonatal RV-C infection led to an enhanced type 2 response when compared to RV-A infection, in part due to poor inflammasome activation and decreased IL-1b production in the RV-C infected animals (203) . Mitigation of this strong type 2 inflammatory response could be achieved with recombinant IFN-g treatment, demonstrating a reciprocal relationship between type 1 and type 2 immunity (204) . Limited preclinical studies exist on neonatal HMPV infection, although unpublished data generated in our laboratory suggest neonatal mice are capable of HMPV clearance similar to RSV models. In children less than <3 years of age with a documented HMPV infection, nasal secretions showed a relative increase in proteins associated with Th1 responses but not Th2 responses; this deviation in Th1/Th2 balance was abrogated in patients with a history of prematurity (205) . In contrast, a second study evaluating nasal protein levels found infants with HMPV infection had a decrease in IFN-g/IL-4 ratio (e.g. Th2-skewing) when compared to RSV and influenza (206) . In summary, the preclinical neonatal models of respiratory viral infection demonstrated an amplification of the baseline neonatal immune response: dampened early antiviral proinflammatory mediators, reduced co-stimulatory help via antigen-presenting cells, poor organization of Tfh/B cell interactions, and reinforced dominance of type 2 immunity. The latter is driven by epithelial-derived cytokines like IL-33, IL-25, and TSLP and contributes to longstanding pathophysiologic changes in some models. Addition of another antigen or allergen synergistically contributed to asthma-like pathology. Collectively, these models demonstrate a skewed, but protective, immune response in neonates compared to adult animals, and help establish a mechanistic link between respiratory viral infection early in life and long-term sequelae like asthma. Several epidemiologic studies have supported the clinically observed phenomenon of development of asthma after an early respiratory viral infection, with a particular focus on RV and RSV (207, 208) . Interestingly, first-time wheeze in young children was predominantly associated with RV (44, 209) . A prospective study of children showed that wheezing with a RV infection in infancy was associated with a significantly higher risk of wheezing at age 3 and a 10-fold increase in risk of diagnosis of asthma at the age of 6 (210, 211) . Similarly, a prospective study of children presenting with bronchiolitis used machine learning clustering to identify risk factors for recurrent wheeze; RV detection was the strongest single predictor (212) . A prospective study found RV-C bronchiolitis in infancy, but not RV-A or -B, was associated with recurrent wheeze and IgE-sensitization compared to infants with RSV bronchiolitis (213) . Genetic-environment interactions play a role in this process, as RV-related recurrent wheeze (but not RSV) was associated with polymorphisms in the 17q21 locus, a well-established susceptibility locus for development of childhood asthma (214, 215) . Similar to RV, an RSV illness with wheeze early in life also showed a significant 3-fold increase in risk of subsequent asthma development (209, 211) . Children with RSV-bronchiolitis that went on to develop asthma were more likely to have an elevated IgE, higher birth weight, or delivery via caesarean section (216) . At age 18, children with a history of RSV bronchiolitis within the first year of life had an increased risk of asthma, allergy, and sensitization to perennial allergens compared to controls; these differences were magnified when accounting for parental history of asthma (217) . Further endotyping of children with RSV bronchiolitis found those with parental asthma, RV coinfection, IgE sensitization, a Moraxella-dominant airway microbiome, and high IFN-g responses had the highest risk of subsequent asthma development, highlighting the myriad factors contributing to this outcome (218) . One study of Danish twins found hospitalization with RSV was associated with increased short-term risk of admission for asthma; asthma admission was also associated with severe RSV, demonstrating a bidirectional association, emphasizing a genetic component (219) . A second twin study found that RSV hospitalization in early childhood may not directly cause asthma but may indicate a genetic predisposition for subsequent asthma development (220) . Large systematic reviews of studies evaluating risk of asthma after RSV infection during infancy demonstrate a higher prevalence of asthma throughout childhood years (221) . Like RSV and RV, HMPV in childhood is associated with development of asthma. Children followed prospectively after a HMPV lower respiratory tract infection were found to have a shorter duration of time between wheezing episodes (both with and without a subsequent viral trigger) when compared to controls without evidence of HMPV infection (222) . Furthermore, patients with a history of HMPV bronchiolitis were much more likely to have asthma by age 5 (odds ratio=5.21) compared to patients without HMPV bronchiolitis (223) . Additionally, HMPV lower respiratory tract infection in premature infants was associated with abnormal lung function at one year of age (224) . In regards to upstream mediators of asthma-like inflammation, HMPV has been shown to induce in vitro expression of IL-33 and TSLP in human alveolar epithelial cells (225) . Clinically, serum levels of TSLP in children with wheeze during HMPV infection were elevated, further potentiating a link between TSLP production and HMPV infection (226) . While specific pathogens have been evaluated, Bønnelykke et al. recently demonstrated that any lower respiratory tract infection (e.g. viral or bacterial) in the first years of life and the frequency of infections were variables associated with increased risk of asthma at age 7 (227) . Additionally, while the focus of this review is on infectious triggers of asthma, childhood-onset asthma represents a multifactorial disease (e.g. genetic, exposures, atopy, microbiome etc.) contributing to pathogenesis (228) . There is a relative dearth of antiviral agents directed against the respiratory viruses reviewed here. Aerosolized ribavirin has been studied in severely ill children with RSV but has demonstrated minimal efficacy (229) . No licensed therapeutic options currently exist for HMPV or RV (18, 30) . Given the lack of effective therapies, the focus has turned to prevention. Vaccination against these respiratory pathogens has been an area of particular emphasis. However, the turbulent experiences of the formalin-inactivated RSV vaccine in the 1960's delayed progress (230) . Infants and toddlers who received the formalin-inactivated RSV vaccine demonstrated worsened outcomes of RSV infection, with 80% requiring hospitalization and two succumbing to infection (231) (232) (233) . Studies have demonstrated a role for Th2-bias leading to the pathology of this enhanced respiratory disease (ERD); this theory was recently strengthened further after transcriptomic analysis of autopsy specimens from the two fatal cases of ERD in toddlers showed a Th2-signature and low-affinity antibodies causing complement deposition (169, (234) (235) (236) (237) . Several candidate vaccines, including live-attenuated, inactivated, particle-based, and subunit based, are in preclinical development or clinical trials (233, 238) . An alternative approach has focused on maternal immunization with passive immunity conferred to the infant; a nanoparticle protein-based vaccine administered in the third trimester showed a significant reduction in hospitalization rate with RSV in the first 90 days of the infant's life (239) . This would, however, be of less utility for premature infants delivered prior to vaccine administration. HMPV vaccines, including protein-based vaccines, live attenuated viruses, and virus-like particles, have shown promise in animal models (240) (241) (242) (243) (244) (245) (246) (247) . However, one clinical trial of a live attenuated HMPV vaccine showed only modest induction of a neutralizing antibody response in 30% of participants (248) . While RV vaccines have proven difficult given the number of serotypes, several approaches are being explored in preclinical models (30, 249, 250) . A degree of prevention has been achieved against RSV with the use of monoclonal antibodies. Palivizumab, a humanized monoclonal antibody directed against the F protein of RSV, decreased hospitalizations in high-risk infants (e.g., prematurity, congenital heart disease, immunodeficiency) when administered monthly (251) (252) (253) . However, cost limits the widespread use of palivizumab (251, 254) . Several other anti-RSV monoclonal antibodies are in development, including a long-acting monoclonal (nirsevimab) capable of offering protection for 5 months (230, 255) . One recent study estimated that a strategic switch from monthly monoclonal injections to either a maternal immunization strategy and/or use of long-acting monoclonals would afford significant cost-savings while providing a similar degree of benefit (256) . Analogous to palivizumab, human monoclonal antibodies against HMPV have been developed; in preclinical models, these monoclonals have been shown to have preventative and therapeutic potential (257, 258) . Interestingly, certain HPMVderived monoclonals show a degree of cross-protection against other Pneumoviridae family members, including RSV (259, 260) . Development of monoclonal antibodies directed against RV has been studied, but face similar hurdles as RV vaccine development (261) . While the search for a safe and effective vaccine and further monoclonal antibodies continues, the COVID-19 pandemic has also illustrated the efficacy of non-pharmaceutical public health measures. From 2020 to 2021, strategies to mitigate COVID-19 such as masking and distancing effectively reduced the case burden of RSV and HMPV (262) . With loosening of these restrictions in the summer of 2021, there was an anomalous increase in pediatric RSV cases in the summer months (262) . Collectively, these findings illustrate that public health approaches represent a cost-effective and, in the absence of a pandemic, a possibly underutilized approach towards protecting infants against respiratory viruses. Respiratory pathogens, such as RSV, HMPV, and RV, are major contributors to morbidity and mortality in the neonatal population. This may be in part due to the unique immunologic milieu of the neonatal lung, which differs from an adult immune response in practically every cell type. Type 2 immunity predominates in the neonatal lung and, in animal models, contributes to long-term pathology. This is mirrored clinically, as infants exposed to these viruses are at increased risk of development of long-term sequelae such as asthma. However, deeper understanding of the underlying immunologic differences in neonates has the potential to impact how clinicians consider these pathologies, both in the acute and long-term settings. For instance, understanding the pre-existing imbalance of type 1 and type 2 immunity in the neonate could lead to development of immunomodulatory therapeutics to boost the former or suppress the latter. Several pre-clinical models have inhibited type 2 immune factors during the acute immune response and mitigated long-term pathology. Preventing an increased risk of asthma in infants with lower respiratory tract viral infections is a lofty but worthy aspiration. From a basic science perspective, there are many new avenues of neonatal lung biology to explore, such as the roles of the neonatal microbiome (lung and gut) and the use of broad -omics based techniques to elucidate novel aspects of neonatal immunity. While the clinical realm awaits the furthered characterization and promise of translation of these findings, respiratory viral infections will continue to present a significant challenge to neonates and infants. Far too many young children still succumb to these infections, with disproportionate mortality in resource-limited areas of the world, highlighting the need for cost-effective interventions. Although therapeutic options are limited at present, advances in vaccination and monoclonal antibody prophylactics are hoped to translate to increased prevention in neonates. TE -drafted and revised manuscript, generated figures. OPdrafted a section of manuscript, helped generate figures, and revised manuscript. JW -drafting/writing of manuscript. All authors contributed to the article and approved the submitted version. Global, Regional, and National Estimates of Pneumonia Morbidity and Mortality in Children Younger Than 5 Years Between 2000 and 2015: A Systematic Analysis Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children in 2015: A Systematic Review and Modelling Study Global Burden of Acute Lower Respiratory Infection Associated With Human Metapneumovirus in Children Under 5 Years in 2018: A Systematic Review and Modelling Study Global Burden of Respiratory Infections Associated With Seasonal Influenza in Children Under 5 Years in 2018: A Systematic Review and Modelling Study Prospective Multicenter Study of Viral Etiology and Hospital Length of Stay in Children With Severe Bronchiolitis Detection of New Respiratory Viruses in Hospitalized Infants With Bronchiolitis: A Three-Year Prospective Study Very Young Infants Severity of Acute Bronchiolitis Depends on Carried Viruses Respiratory Syncytial Virus-a Comprehensive Review Global Patterns in Monthly Activity of Influenza Virus, Respiratory Syncytial Virus, Parainfluenza Virus, and Metapneumovirus: A Systematic Analysis Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus Immune Responses and Disease Enhancement During Respiratory Syncytial Virus Infection Respiratory Syncytial Virus Prevention and Therapy: Past, Present, and Future National Disease Burden of Respiratory Viruses Detected in Children by Polymerase Chain Reaction Respiratory Syncytial Virus-Coded Pediatric Hospitalizations A Newly Discovered Human Pneumovirus Isolated From Young Children With Respiratory Tract Disease Analysis of the Genomic Sequence of a Human Metapneumovirus Human Metapneumovirus: Lessons Learned Over the First Decade Human Metapneumovirus Subgroup Changes and Seasonality During Epidemics Clinical Findings and Unusual Epidemiologic Characteristics of Human Metapneumovirus Infections in Children in the Region of Seasonality and Clinical Features of Human Metapneumovirus Infection in Children in Northern Alberta Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children The Role of Human Metapneumovirus in Upper Respiratory Tract Infections in Children: A 20-Year Experience A 1-Year Experience With Human Metapneumovirus in Children Aged <5 Years Outbreak of Human Metapneumovirus Infection in Norwegian Children Burden of Human Metapneumovirus Infection in Young Children Human Metapneumovirus in the Preterm Neonate: Current Perspectives The Burden of Single Virus and Viral Coinfections on Severe Lower Respiratory Tract Infections Among Preterm Infants: A Prospective Birth Cohort Study in Brazil Clinical and Virological Characteristics of Early and Moderate Preterm Infants Readmitted With Viral Respiratory Infections Human Rhinoviruses Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution Analysis of the Complete Genome Sequences of Human Rhinovirus Rhinovirus Infections in an Industrial Population. I. The Occurrence of Illness Picornavirus Infections in Children Diagnosed by RT-PCR During Longitudinal Surveillance With Weekly Sampling: Association With Symptomatic Illness and Effect of Season Serial Viral Infections in Infants With Recurrent Respiratory Illnesses Swiss Paediatric Respiratory Research Group. Viral Etiology of Acute Respiratory Infections With Cough in Infancy: A Community-Based Birth Cohort Study Viral Respiratory Infections in Hospitalized and Community Control Children in Alaska Human Picornavirus and Coronavirus RNA in Nasopharynx of Children Without Concurrent Respiratory Symptoms Acute Respiratory Illness in the Community. Frequency of Illness and the Agents Involved Frequency and Natural History of Rhinovirus Infections in Adults During Autumn Human Rhinoviruses: The Cold Wars Resume Impact of Rhinovirus Infections in Children The First Wheezing Episode: Respiratory Virus Etiology, Atopic Characteristics, and Illness Severity Role of Respiratory Viruses in Acute Upper and Lower Respiratory Tract Illness in the First Year of Life: A Birth Cohort Study Etiology of Community-Acquired Pneumonia in 254 Hospitalized Children Association of Rhinovirus Infection With Increased Disease Severity in Acute Bronchiolitis Clinical Features of Patients With Acute Respiratory Illness and Rhinovirus in Their Bronchoalveolar Lavages Rhinovirus-Associated Wheezing in Infancy: Comparison With Respiratory Syncytial Virus Bronchiolitis Rhinovirus Infections in Infancy and Early Childhood Rhinovirus-Associated Hospitalizations in Young Children Nosocomial Rhinovirus Infection in Preterm Infants Human Rhinoviruses in Severe Respiratory Disease in Very Low Birth Weight Infants Human Rhinovirus Causes Severe Infection in Preterm Infants Ontogeny of Ia+ Accessory Cells in Fetal and Newborn Rat Lung NF-kb Signaling in Fetal Lung Macrophages Disrupts Airway Morphogenesis Emergence of NK-Cell Progenitors and Functionally Competent NK-Cell Lineage Subsets in the Early Mouse Embryo Development of Interleukin-17-Producing gd T Cells Is Restricted to a Functional Embryonic Wave Neonatal Immunity to Respiratory Viruses Two Waves of Distinct Hematopoietic Progenitor Cells Colonize the Fetal Thymus Mucin Production During Prenatal and Postnatal Murine Lung Development Muc5b Is Required for Airway Defence Surfactant Protein (SP)-A Suppresses Preterm Delivery and Inflammation via TLR2 Surfactant Protein Secreted by the Maturing Mouse Fetal Lung Acts as a Hormone That Signals the Initiation of Parturition Surfactant Proteins A and D Inhibit the Growth of Gram-Negative Bacteria by Increasing Membrane Permeability Diverse Homeostatic and Immunomodulatory Roles of Immune Cells in the Developing Mouse Lung at Single Cell Resolution Alveolar Macrophages Develop From Fetal Monocytes That Differentiate Into Long-Lived Cells in the First Week of Life via GM-CSF Defective Macrophage Function in Neonates and Its Impact on Unresponsiveness of Neonates to Polysaccharide Antigens M2 Macrophage Polarisation Is Associated With Alveolar Formation During Postnatal Lung Development Phagocytosis-Associated Functions in Neonatal Monocyte-Derived Macrophages Impaired Functional Capacity of Polarised Neonatal Macrophages The Warburg Effect Occurs Rapidly in Stimulated Human Adult But Not Umbilical Cord Blood Derived Macrophages Cytokine Receptor Signalling in Neonatal Macrophages: Defective STAT-1 Phosphorylation in Response to Stimulation With IFN-Gamma Phenotype of Fetal Monocytes and B Lymphocytes During the Third Trimester of Pregnancy Neonatal Monocytes Demonstrate Impaired Homeostatic Extravasation Into a Microphysiological Human Vascular Model Quantitative and Qualitative Deficits in Neonatal Lung-Migratory Dendritic Cells Impact the Generation of the CD8+ T Cell Response Development of the Dendritic Cell System During Mouse Ontogeny Neonatal Dendritic Cells Are Intrinsically Biased Against Th-1 Immune Responses Interferon Regulatory Factor 3-Dependent Responses to Lipopolysaccharide Are Selectively Blunted in Cord Blood Cells Deficient IL-12(P35) Gene Expression by Dendritic Cells Derived From Neonatal Monocytes Neonatal Immunity: Faulty T-Helpers and the Shortcomings of Dendritic Cells Blood Plasmacytoid Dendritic Cell Responses to CpG Oligodeoxynucleotides Are Impaired in Human Newborns Interferon Regulatory Factor 7-Mediated Responses Are Defective in Cord Blood Plasmacytoid Dendritic Cells Upon TLR9 Signaling, CD5+ B Cells Control the IL-12-Dependent Th1-Priming Capacity of Neonatal DCs Neonatal B Cells Suppress Innate Toll-Like Receptor Immune Responses and Modulate Alloimmunity Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells Phenotype and Function of Neonatal DC Environmental Signals Rather Than Layered Ontogeny Imprint the Function of Type 2 Conventional Dendritic Cells in Young and Adult Mice Neutrophil and Endothelial Adhesive Function During Human Fetal Ontogeny Evolution of the Immune System in Humans From Infancy to Old Age Phagocytic Ability of Neutrophils and Monocytes in Neonates Impaired Neutrophil Extracellular Trap (NET) Formation: A Novel Innate Immune Deficiency of Human Neonates Immune Responses in Neonates Decreased Functional Caspase-3 Expression in Umbilical Cord Blood Neutrophils Is Linked to Delayed Apoptosis Mechanisms Underlying Reduced Apoptosis in Neonatal Neutrophils Neutrophilic Myeloid-Derived Suppressor Cells in Cord Blood Modulate Innate and Adaptive Immune Responses Differentiation and Functional Regulation of Human Fetal NK Cells High Expression of NKG2A/ CD94 and Low Expression of Granzyme B Are Associated With Reduced Cord Blood NK Cell Activity Natural Killer Cell Responses to Infections in Early Life Inhibitory Receptor Expression on Neonatal Immune Cells TLR3 Impairment in Human Newborns Potent Induction of IFN-g Production From Cord Blood NK Cells by the Stimulation With Single-Stranded RNA Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections Interleukin-12 Induces Interferon-Gamma Expression and Natural Killer Cytotoxicity in Cord Blood Mononuclear Cells Human NK Cells Display Major Phenotypic and Functional Changes Over the Life Span TGF-b Is Responsible for NK Cell Immaturity During Ontogeny and Increased Susceptibility to Infection During Mouse Infancy Neonatal Adaptive Immunity Comes of Age Actively Acquired Tolerance of Foreign Cells Neonatal Tolerance Revisited: Turning on Newborn T Cells With Dendritic Cells Single Cell RNA Analysis Identifies Cellular Heterogeneity and Adaptive Responses of the Lung at Birth Lymphocyte Subsets Show Marked Differences in Their Distribution Between Blood and the Afferent and Efferent Lymph of Peripheral Lymph Nodes Control of Neonatal Tolerance to Naive and Memory T Cells Show Distinct Pathways of Lymphocyte Recirculation Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans Developmental Origin Governs CD8+ T Cell Fate Decisions During Infection Neonatal T Cells: A Reinterpretation B-1 B Cell Development in the Fetus and Adult Toward a Layered Immune System Peripheral CD4+ Lymphocytes Derived From Fetal Versus Adult Thymic Precursors Differ Phenotypically and Functionally Fetal and Adult Progenitors Give Rise to Unique Populations of CD8+ T Cells Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus Induction of Protective Immunity to Listeria Monocytogenes in Neonates Modeling the Dynamics of Neonatal CD8+ T-Cell Responses Rapid Proliferation and Differentiation Impairs the Development of Memory CD8+ T Cells in Early Life Rapid CD8(+) Function Is Critical for Protection of Neonatal Mice From an Extracellular Bacterial Enteropathogen CD8+ T Cells From Human Neonates Are Biased Toward an Innate Immune Response IL-12 Signaling Contributes to the Reprogramming of Neonatal CD8+ T Cells Neonatal CD8+ T-Cell Differentiation Is Dependent on Interleukin-12 Default" Generation of Neonatal Regulatory T Cells T Cell Receptor Repertoire Diversity and Clonal Expansion in Human Neonates Alterations in the Thymic Selection Threshold Skew the Self-Reactivity of the TCR Repertoire in Neonates T Cell-Positive Selection Uses Self-Ligand Binding Strength to Optimize Repertoire Recognition of Foreign Antigens Reduced Generation of Lung Tissue-Resident Memory T Cells During Infancy Induction of TH1 and TH2 Immunity in Neonatal Mice Enhanced Type 2 and Diminished Type 1 Cytokines in Neonatal Tolerance The Generation of Th Memory in Neonates Versus Adults: Prolonged Primary Th2 Effector Function and Impaired Development of Th1 Memory Effector Function in Murine Neonates Freshly Isolated, Murine Neonatal T Cells Produce IL-4 in Response to Anti-CD3 Stimulation Murine Neonatal CD4+ Cells Are Poised for Rapid Th2 Effector-Like Function The Human IL-13 Locus in Neonatal CD4+ T Cells Is Refractory to the Acquisition of a The Murine Th2 Locus Undergoes Epigenetic Modification in the Thymus During Fetal and Postnatal Ontogeny IL-4 Utilizes an Alternative Receptor to Drive Apoptosis of Th1 Cells and Skews Neonatal Immunity Toward Th2 Developmental Expression of IL-12rb2 on Murine Naive Neonatal T Cells Counters the Upregulation of IL-13ra1 on Primary Th1 Cells and Balances Immunity in the Newborn Delayed Maturation of an IL-12-Producing Dendritic Cell Subset Explains the Early Th2 Bias in Neonatal Immunity Immune Tolerance. Regulatory T Cells Generated Early in Life Play a Distinct Role in Maintaining Self-Tolerance Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T CellsIn Utero A Genetic Model Reveals Biological Features of Neonatal CD4 Helper Cells Undergone Homeostasis in Mice Neonatal T Helper 17 Responses Are Skewed Towards an Immunoregulatory Interleukin-22 Phenotype Helper Cell Biology: A Decade of Discovery and Diseases Environmental and T Cell-Intrinsic Factors Limit the Expansion of Neonatal Follicular T Helper Cells But may be Circumvented by Specific Adjuvants Neonatal Follicular Th Cell Responses Are Impaired and Modulated by IL-4 Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7 (-/)-Mice Formation of B-1 B Cells From Neonatal B-1 Transitional Cells Exhibits NF-kb Redundancy Immunization of Newborn Mice Accelerates the Architectural Maturation of Lymph Nodes, But AID-Dependent IgG Responses Are Still Delayed Compared to the Adult Human B1 Cells in Umbilical Cord and Adult Peripheral Blood Express the Novel Phenotype CD20+ CD27+ CD43+ CD70 Isolation From Human Placenta of the IgG Transporter, FcRn, and Localization to the Syncytiotrophoblast: Implications for Maternal-Fetal Antibody Transport Influence of Maternal Antibodies on Neonatal Immunization Against Respiratory Viruses Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators Eosinophil Accumulation in Postnatal Lung Is Specific to the Primary Septation Phase of Development Stimulation of Immature Lung Macrophages With Intranasal Interferon Gamma in a Novel Neonatal Mouse Model of Respiratory Syncytial Virus Infection Neonatal CD8 T-Cell Hierarchy Is Distinct From Adults and Is Influenced by Intrinsic T Cell Properties in Respiratory Syncytial Virus Infected Mice Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33 Responsiveness to Respiratory Syncytial Virus in Neonates Is Mediated Through Thymic Stromal Lymphopoietin and OX40 Ligand Limited Type I Interferons and Plasmacytoid Dendritic Cells During Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis Upon Reinfection Type I IFN Ineffectively Activates Neonatal Dendritic Cells Limiting Respiratory Antiviral T-Cell Responses The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity During Adult Reinfection of Neonatally Sensitized Mice Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates Localization of the T-Cell Response to RSV Infection Is Altered in Infant Mice IL-4ra on CD4+ T Cells Plays a Pathogenic Role in Respiratory Syncytial Virus Reinfection in Mice Infected Initially as Neonates The Specific Features of the Developing T Cell Compartment of the Neonatal Lung Are a Determinant of Respiratory Syncytial Virus Immunopathogenesis Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity Exposure of Neonates to Respiratory Syncytial Virus Is Critical in Determining Subsequent Airway Response in Adults The Enhancement or Prevention of Airway Hyperresponsiveness During Reinfection With Respiratory Syncytial Virus Is Critically Dependent on the Age at First Infection and IL-13 Production Early Infection With Respiratory Syncytial Virus Impairs Regulatory T Cell Function and Increases Susceptibility to Allergic Asthma Building a Better Neonatal Mouse Model to Understand Infant Respiratory Syncytial Virus Disease Immunomodulation With IL-4R Alpha Antisense Oligonucleotide Prevents Respiratory Syncytial Virus-Mediated Pulmonary Disease STAT6 Inhibitory Peptide Given During RSV Infection of Neonatal Mice Reduces Exacerbated Airway Responses Upon Adult Reinfection Virus-Specific IgE Enhances Airway Responsiveness on Reinfection With Respiratory Syncytial Virus in Newborn Mice Transforming Growth Factor Beta Is a Major Regulator of Human Neonatal Immune Responses Following Respiratory Syncytial Virus Infection Alveolar Macrophages Support Interferon Gamma-Mediated Viral Clearance in RSV-Infected Neonatal Mice Delivery of Cytokines by Recombinant Virus in Early Life Alters the Immune Response to Adult Lung Infection Respiratory Syncytial Virus Infection of Newborn CX3CR1-Deficient Mice Induces a Pathogenic Pulmonary Innate Immune Response T280M Variation of the CX3C Receptor Gene Is Associated With Increased Risk for Severe Respiratory Syncytial Virus Bronchiolitis Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity Neonatal Antibody Responses Are Attenuated by Interferon-g Produced by NK and T Cells During RSV Infection Enhanced IL-2 in Early Life Limits the Development of TFH and Protective Antiviral Immunity Type I Interferon Potentiates Iga Immunity to Respiratory Syncytial Virus Infection During Infancy The Pneumonia Virus of Mice (PVM) Model of Acute Respiratory Infection Pneumonia Virus of Mice: Severe Respiratory Infection in a Natural Host Inflammatory Responses to Acute Pneumovirus Infection in Neonatal Mice HMGB1 Amplifies ILC2-Induced Type-2 Inflammation and Airway Smooth Muscle Remodelling Aeroallergen-Induced IL-33 Predisposes to Respiratory Virus-Induced Asthma by Dampening Antiviral Immunity Early-Life Viral Infection and Allergen Exposure Interact to Induce an Asthmatic Phenotype in Mice Neonatal Rhinovirus Infection Induces Mucous Metaplasia and Airways Hyperresponsiveness The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice Neonatal Rhinovirus Induces Mucous Metaplasia and Airways Hyperresponsiveness Through IL-25 and Type 2 Innate Lymphoid Cells Barrier Epithelial Cells and the Control of Type 2 Immunity Early-Life Heterologous Rhinovirus Infections Induce an Exaggerated Asthma-Like Phenotype Deficient Inflammasome Activation Permits an Exaggerated Asthma Phenotype in Rhinovirus C-Infected Immature Mice IFN-g Blocks Development of an Asthma Phenotype in Rhinovirus-Infected Baby Mice by Inhibiting Type 2 Innate Lymphoid Cells Premature Infants Have Impaired Airway Antiviral Ifng Responses to Human Metapneumovirus Compared to Respiratory Syncytial Virus Cytokine Profiles in the Respiratory Tract During Primary Infection With Human Metapneumovirus, Respiratory Syncytial Virus, or Influenza Virus in Infants Asthma and Viral Infections: An Intricate Relationship Association Between Early Viral LRTI and Subsequent Wheezing Development, a Meta-Analysis and Sensitivity Analyses for Studies Comparable for Confounding Factors Early-Life Respiratory Viral Infections, Atopic Sensitization, and Risk of Subsequent Development of Persistent Asthma Rhinovirus Illnesses During Infancy Predict Subsequent Childhood Wheezing Wheezing Rhinovirus Illnesses in Early Life Predict Asthma Development in High-Risk Children Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma A Large-Scale, Consortium-Based Genomewide Association Study of Asthma Recurrent Wheezing and Asthma After Respiratory Syncytial Virus Bronchiolitis Asthma and Allergy Patterns Over 18 Years After Severe RSV Bronchiolitis in the First Year of Life Integrated Omics Endotyping of Infants With Respiratory Syncytial Virus Bronchiolitis and Risk of Childhood Asthma The Causal Direction in the Association Between Respiratory Syncytial Virus Hospitalization and Asthma Exploring the Association Between Severe Respiratory Syncytial Virus Infection and Asthma: A Registry-Based Twin Study Elevated Risk of Asthma After Hospitalization for Respiratory Syncytial Virus Infection in Infancy Recurrent Wheezing in Children Following Human Metapneumovirus Infection Human Metapneumovirus Bronchiolitis in Infancy Is an Important Risk Factor for Asthma at Age 5 Lung Function in Prematurely Born Infants After Viral Lower Respiratory Tract Infections Human Metapneumovirus Infection Activates the TSLP Pathway That Drives Excessive Pulmonary Inflammation and Viral Replication in Mice Elevated Serum Levels of Thymic Stromal Lymphopoietin in Wheezing Children Infected With Human Metapneumovirus Association Between Respiratory Infections in Early Life and Later Asthma Is Independent of Virus Type The Role of Atopy in Asthma Development and Persistence Therapy for Respiratory Tract Infections Caused by Respiratory Syncytial Virus The Respiratory Syncytial Virus Vaccine Landscape: Lessons From the Graveyard and Promising Candidates Respiratory Syncytial Virus Disease in Infants Despite Prior Administration of Antigenic Inactivated Vaccine Field Evaluation of a Respiratory Syncytial Virus Vaccine and a Trivalent Parainfluenza Virus Vaccine in a Pediatric Population Progress Toward a Respiratory Syncytial Virus Vaccine Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (But Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection Lack of Antibody Affinity Maturation Due to Poor Toll-Like Receptor Stimulation Leads to Enhanced Respiratory Syncytial Virus Disease Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease Fatal Enhanced Respiratory Syncytial Virus Disease in Toddlers Vaccine and mAb Snapshot. (2021) PATH snapshot Respiratory Syncytial Virus Vaccination During Pregnancy and Effects in Infants A Host-Range Restricted Parainfluenza Virus Type 3 (PIV3) Expressing the Human Metapneumovirus (hMPV) Fusion Protein Elicits Protective Immunity in African Green Monkeys Immunization With a Recombinant Bacillus Calmette-Guerin Strain Confers Protective Th1 Immunity Against the Human Metapneumovirus Infection of Nonhuman Primates With Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates Deletion of M2 Gene Open Reading Frames 1 and 2 of Human Metapneumovirus: Effects on RNA Synthesis, Attenuation, and Immunogenicity Generation of Temperature-Sensitive Human Metapneumovirus Strains That Provide Protective Immunity in Hamsters Immunogenicity and Efficacy of Two Candidate Human Metapneumovirus Vaccines in Cynomolgus Macaques Human Metapneumovirus Virus-Like Particles Induce Protective B and T Cell Responses in a Mouse Model Virus-Like Particle Vaccine Induces Cross-Protection Against Human Metapneumovirus Infections in Mice Experimental Infection of Adults With Recombinant Wild-Type Eddens et al. Neonatal Immunity to Respiratory Viruses Frontiers in Immunology | www A Polyvalent Inactivated Rhinovirus Vaccine Is Broadly Immunogenic in Rhesus Macaques Developing a Vaccine for Human Rhinoviruses Monoclonal Antibody for Reducing the Risk of Respiratory Syncytial Virus Infection in Children Review of Palivizumab in the Prophylaxis of Respiratory Syncytial Virus (RSV) in High-Risk Infants Dutch RSV Neonatal Network. Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants Cost-Effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants Effectiveness and Cost-Effectiveness of RSV Infant and Maternal Immunization Programs: A Case Study of Nunavik Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human MetapneumovirusIn Vitro and In Vivo A Recombinant Human Monoclonal Antibody to Human Metapneumovirus Fusion Protein That Neutralizes Virus In Vitro and Is Effective Therapeutically In Vivo Cross-Neutralization of Four Paramyxoviruses by a Human Monoclonal Antibody A Broadly Neutralizing Human Monoclonal Antibody Exhibits In Vivo Efficacy Against Both Human Metapneumovirus and Respiratory Syncytial Virus The Application of Prophylactic Antibodies for Rhinovirus Infections Centers for Disease Control and Prevention. Health. The National Respiratory and Enteric Virus Surveillance System (NREVSS). In: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases Center for Disease Control and prevention Conflict of Interest: The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The handling editor KE declared a shared affiliation with the author OP at the time of review.